Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Two New Tapentadol Formulations vs PR Tablet
NCT03956134Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2005
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tapentadol in pain (5 arms), sponsored by Grünenthal GmbH. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time zero to last quantifiable concentration and 2 more. Started Apr 2005; status: completed.
02
Drugs
tapentadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03956134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03956134.